Insights On Solid Dose Manufacturing

51. Early Development Considerations For NCE Success: Quality Systems 3/1/2024

    Leveraging robust quality systems can improve efficiency throughout the product development lifecycle and help companies avoid unnecessary knowledge and tech transfer, saving both time and cost.

52. How To Avoid Sticking And Picking In The Tableting Industry 9/23/2024

    Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.

53. Key Considerations In Isolator Design With AST And Germfree 3/26/2024

    Josh Russell, VP of Sales and Marketing at AST, and Brandon Serle, Value Stream Manager at Germfree, share insights into their collaborative process in designing a groundbreaking new isolator, heavily influenced by user feedback.

54. Meeting An Aggressive Go-To-Clinic Timeline 9/27/2023

    Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensuring patients in need receive treatment in a timely manner.

55. Key To Formulation Development Is In The Details 7/20/2023

    Find out how to face the challenges in tablet manufacturing environments through supportive vendor partnerships.

56. A Technology Driven CDMO & Trusted Manufacturing Partner 7/18/2024

    Whether it's through extended release formulations or titratable dosage forms, we are dedicated to addressing the specific needs of different patient populations, including pediatrics and geriatrics.

57. Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets 1/27/2025

    Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.

58. An Alternative Method Of Drug-Excipient Characterization 12/30/2024

    Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

59. Challenges Associated With Building New Isolator Technology 3/26/2024

    Paula Rizo, Germfree’s Mechanical Engineering Lead for Equipment, dives deeper into our collaboration with AST and how this isolator technology will transform the way pharmaceutical companies approach aseptic processing.

60. Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives 7/17/2024

    A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.